-- ヒンドゥスタン・ジンク(NSE:HINDZINC、BOM:500188)は、3月31日を期末とする会計年度第4四半期の連結純利益が503億インドルピーとなり、前年同期の300億インドルピーから増加したと発表した。 同社が金曜日にインド証券取引所に提出した資料によると、1株当たり利益は前年同期の7.11ルピーから11.91ルピーに上昇した。 同社の株価は月曜日の取引で約5%上昇した。 会計年度第4四半期の営業収益も前年同期の909億ルピーから1354億ルピーに急増した。 さらに、同社は2026-27会計年度の第1回中間配当を1株当たり11ルピーとし、4月30日現在の株主名簿に記載されている株主に対して支払うと発表した。
Related Articles
Dongjiang Environmental's Loss Widens 2.7% in Q1
Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.
Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday
Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.
Zuoli Kechuang Logs Drop in Q1 Profit
Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.